BankChampaign National Association’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.09M Buy
2,577
+1,456
+130% +$1.49M 2.37% 4
2026
Q1
$1.03M Buy
1,121
+53
+5% +$53.7K 1.02% 26
2025
Q4
$1.15M Buy
+1,068
New +$1.02M 1.13% 23

Other funds holding LLY

BankChampaign National Association's LLY Position: Q2 2026 in Review

BankChampaign National Association increased its Eli Lilly (LLY) stake by 130% in Q2 2026, buying an estimated $1.49M and bringing the position to 2,577 shares worth $3.09M. The position accounts for 2.37% of the portfolio, ranked #4.

BankChampaign National Association first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BankChampaign National Association held 2,577 shares of Eli Lilly worth $3.09M as of Q2 2026.
  • BankChampaign National Association bought 1,456 Eli Lilly shares in Q2 2026, an estimated $1.49M.
  • Eli Lilly made up 2.37% of BankChampaign National Association's portfolio in Q2 2026, its #4 holding.
  • BankChampaign National Association first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BankChampaign National Association's 13F filing for Q2 2026, filed 23 Jul 2026.